Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

gi- high risk if you think about averaging down. There is a lot up in the air.

Stagnant increase in sales, no ANDA, lack of marketing channels, etc.

I would just wait until the Q4 report. I doubt very much this stock will make any significant run.